Clayton, Dubilier & Rice banks one of the cleanest mid-market industrial partial exits of 2026, three and a half years after carving the portfolio out of Roper Technologies. Ametek pays a full multiple for picks-and-shovels exposure to the AI-infrastructure trade.
Ametek, the Pennsylvania-based scientific-and-industrial-instrumentation company, has agreed to acquire the test-and-measurement businesses of Indicor for approximately $5bn. The deal was first reported by the Wall Street Journal in late April when the two parties entered exclusive negotiations, and is the largest single partial exit Clayton, Dubilier & Rice has executed in 2026.
Indicor itself is a 16-brand industrial-instrumentation portfolio (Alpha, AMOT, CCC, Cornell, Dynisco, Roper Pump, Struers, Uson, and others) that originated as a 2022 carve-out from Roper Technologies, with CD&R taking a 51 per cent majority stake at a $3.6bn enterprise value and Roper retaining a 49 per cent minority equity interest plus $2.6bn in upfront cash.
The new company adopted the Indicor brand name in January 2023 and combined approximately $1.1bn in 2022 revenue across pumps, valves, test-and-measurement equipment, sensors, and meters.
The 💜 of EU tech
The latest rumblings from the EU tech scene, a story from our wise ol' founder Boris, and some questionable AI art. It's free, every week, in your inbox. Sign up now!
Ametek is not buying the whole portfolio. The deal is for the test-and-measurement subset specifically; the pumps-and-valves businesses (Roper Pump, Cornell, AMOT, Hansen) remain inside Indicor under CD&R's continued majority ownership. Per Private Equity Wire's confirmation, the assets are precisely aligned with Ametek's existing instrumentation core, precision measurement, materials testing, polymer-process analytics, process-control sensors, categories the company has been rolling up through bolt-on acquisitions for two decades.
On the disclosed numbers, CD&R is selling roughly half the Indicor portfolio for $5bn after acquiring the entire portfolio at a $3.6bn enterprise value four years ago. Per Private Equity Insights' deal analysis, the implied multiple lands in the 12-14x EBITDA range, and the firm is on track for a 2.5–3.5x money multiple on its original equity once the remaining pumps-and-valves businesses exit separately.
That is, by current mid-market industrial-buyout standards, exceptional. The 2025-early 2026 environment for PE industrial exits has been visibly difficult, with rising rates and compressed strategic-buyer multiples making clean exits hard to clear.
Roper, the original seller, also benefits. Per its 2022 announcement, its 49 per cent minority interest entitles it to a proportional share of exit proceeds. Wednesday's transaction returns material cash to Roper on top of the original $2.6bn, useful side validation of its decision to divest the industrial businesses in favour of higher-multiple software operations.
Most strategic M&A coverage in 2026 has run through AI infrastructure and frontier-model distribution. TNW reported this week on Blackstone-KKR-Google AI tie-up talks, Blackstone's $1.75bn data-centre REIT IPO, the Anthropic services firm launch, and OpenAI's $10bn DeployCo close.
The Ametek-Indicor deal is none of those, but its underlying customer base (semiconductor manufacturers, pharmaceutical producers, aerospace-and-defence integrators, energy-sector operators) is exactly the cohort the AI build-out is feeding through the supply chain. Ametek is, in this frame, one of the cleaner picks-and-shovels public-market positions in the AI-infrastructure trade, without ever describing itself in those terms.
Samsung Electronics crossing $1tn on AI memory demand; STMicroelectronics' $3bn space-chip revenue target is the same pattern. The instrumentation companies that test, measure, and validate the chips and process flows behind those numbers are beneficiaries of every part of the build-out simultaneously. The combined Ametek-plus-Indicor revenue base will approach $9bn.
The deal is expected to close in the second half of 2026, subject to regulatory approval. CD&R will prepare the remaining pumps-and-valves businesses for a separate exit. Ametek will execute the integration, in the same disciplined way it has executed its previous bolt-ons. None of this is glamorous. All of it, on the available evidence, compounds.